Ibrutinib for the Treatment of AIHA in Patients With CLL/SLL or CLL-like MBL

Clinical trial NCT05694312 · RECRUITING

Trial details

NCT number: NCT05694312
Sponsor: Gruppo Italiano Malattie EMatologiche dell'Adulto
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Autoimmune Hemolytic Anemia Chronic Lymphocytic Leukemia Small Lymphocytic Lymphoma Monoclonal B-Cell Lymphocytosis CLL-Type

Start date: 2023-11-24
Primary completion: 2025-05-01
Enrollment: 45

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.